Related Experiment Video
Updated: Aug 11, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
[Ischemic heart disease lethalities in the state of Rio de Janeiro between 1999 and 2003]
Gláucia Maria Moraes de Oliveira1, Carlos Henrique Klein, Nelson Albuquerque de Souza e Silva
1Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Escola Nacional de Saúde Pública, Rio de Janeiro, RJ. glaucia@mls.com.br
Insights
High lethality rates for ischemic heart disease (IHD) procedures like coronary artery bypass graft (CABG) and percutaneous transluminal coronary angioplasty (PTCA) were observed in Rio de Janeiro. Optimized medical therapy may be a better option for many IHD patients.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Health Services Research
Context:
- Ischemic heart disease (IHD) management in Rio de Janeiro (RJ) between 1999-2003.
- Analysis of procedures within the Hospital Information System/Single Healthcare System (SIH/SUS).
- Focus on coronary artery bypass graft (CABG) and percutaneous transluminal coronary angioplasty (PTCA).
Purpose:
- To estimate the lethality rates of IHD, CABG, and PTCA procedures in RJ hospitals.
- To compare lethality rates across different IHD classifications and treatments.
- To evaluate the effectiveness of medical therapy versus interventional procedures.
Summary:
- Lethality rates for IHD were 2.8% (angina), 16.2% (acute myocardial infarction), 2.9% (other acute IHD), and 3.9% (chronic IHD).
- Adjusted lethality rates for CABG ranged from 1.9% to 12.8%, and for PTCA, it was 3.2%.
- Medical therapy showed lower lethality (2.3% for CABG, 11.1% for PTCA) compared to procedures in some cases.
Impact:
- Identified high lethality rates for IHD procedures, exceeding desirable levels, particularly for chronic IHD.
- Suggests optimized medical therapy as a preferred option, reserving CABG and PTCA for severe cases.
- Highlights the need for improved treatment strategies for cardiovascular diseases in the region.
Objective:
To estimate the lethality rate of acute and chronic ischemic heart disease (IHD) procedures, coronary artery bypass graft (CABG) procedures and percutaneous transluminal coronary angioplasty (PTCA) procedures in the hospitals that are registered as service providers for the Hospital Information System/Single Healthcare System (SIH/SUS) plan in the state of Rio de Janeiro (RJ) between 1999 and 2003.
Methods:
The procedures considered as CABGs and PTCAs were provided by Datasus (SUS databank). The rates were standardized in accordance with gender, age, and disease severity. The common factors among these procedures are that they are highly complex cardiovascular procedures performed in RJ in the year 2000. The IHD groups are: angina, acute myocardial infarction, other acute IHDs and chronic IHDs.
Results:
Lethality rates for angina, acute myocardial infarction (AMI), other acute and chronic IHDs were 2.8%, 16.2%, 2.9% and 3.9%, respectively, in the RJ. The lethality rates for CABG and PTCA, adjusted by age, sex and diagnostic groups, were elevated ranging from 1.9% to 12.8% for CABG procedures and as high as 3.2% for PTCA. When medical therapy was performed the rates were 2.3% for CABG and 11.1% for PTCA.
Conclusion:
There has been a progressive increase in the number of CABG and PTCA procedures to treat IHDs in the RJ. Lethality rates were above the desirable level, mainly for chronic IHD hospital admissions (5.4% and 1.7%, respectively). Optimized medical therapy appears to be a worthwhile therapeutic option, reserving CABG and PTCA procedures for the cases with the worst prognoses. Lethality rates for AMI with medical therapy was comparable to current rates when thrombolytics were not used (16.7%).
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Coronary Artery Disease III: Clinical Manifestations
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
